Join
Live feed
·
PRReleasevia Quantisnow
Virax Biolabs Group Limited logo

Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds

ByQuantisnow·Wall Street's wire, on your screen.
VRAX· Virax Biolabs Group Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRAX (Virax Biolabs Group Limited) and more on Quantisnow.